Format

Send to:

Choose Destination
See comment in PubMed Commons below
J Cardiovasc Nurs. 2013 Mar-Apr;28(2):147-56. doi: 10.1097/JCN.0b013e31823cbef8.

Assessing and managing metabolic syndrome and cardiovascular risk in midlife women.

Author information

  • 1School of Nursing, Yale University, New Haven, Connecticut, USA. jessica.coviello@yale.edu

Abstract

BACKGROUND:

The components of metabolic syndrome (MetS), a major cardiovascular risk in women that includes diabetes, hypertension, and dyslipidemia, can evolve during the perimenopause transition. Lifestyle interventions have been shown to ameliorate or prevent individual components of MetS.

PURPOSE:

This article will describe the hormonal and vascular changes occurring during perimenopause and discuss how they set the stage for MetS in women. The available screening tools (Framingham Assessment for Coronary Heart Disease vs Framingham General Cardiovascular Risk Profile vs Reynolds Risk Assessment) will be compared and contrasted within the context of the 2011 Updated Guidelines for the Prevention of Cardiovascular Disease in Women via case study.

CONCLUSIONS AND CLINICAL IMPLICATIONS:

Target goals and interventions to reduce or ameliorate the components of MetS will be presented, with a focus on achieving ideal cardiovascular health.

PMID:
22635057
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Lippincott Williams & Wilkins
    Loading ...
    Write to the Help Desk